The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
keeps ticking up.
Exactly. That’s not punt money. Someone is hoovering up stock here for a reason and spending big.
Not a great day but after the rise we have had always going to have pull back at some point. What gives me real confidence is the massive buys that have just come through from yesterday, in the long term only one way this is heading! Sit tight and relax patience is key here and you will be rewarded!
Cheers guys.
I have the App, but cannot seem to get the link to work.
**********************HkgNOBegu0f_uURKbm3GNw
That is the link all welcome to join
I can’t find how to get the link. Hopefully someone will post it up for you.
You need to download the app aswell.
BritishHarrier,
How do we get involved with the Telegram Chat? The amount of space cadets posting on LSE is getting ridiculous.
Thanks
This board is quiet for such a good company
Vol. Sold 891,647
Sold Value £147.12k
Vol. Bought 2,844,148
Bought Value £469.28k
Holding 100k and might sell some when it's 50p. Shouldn't take long. The ride from 2p to 16p was fast might slow down now but its going up for nice profit
is as close with OKYO as he was with his predictions at tils , there's a nice ride coming.
I do hope you are correct. I have taken a position in here for the long term and have faith with the BOD and can’t believe they would be involved unless they believe in it ala Tils
You can buy £10k now looks like they cleared an order.
Nice weather with nice news here looking at SP, the targeted market for dry eye treatment has the potential to be absolutely massive. I did say potential so hopefully potentially it's OKYO that fills the markets needs.
Looks like they are on to a winner with this eye treatment.
18p getting hammered hard to buy in bulk and 17.83p to sell. Once this big order is worked market makers should then let this go. Look at those delayed buys of 100k and 50k first thing
Can’t buy. Got some at 17.4 on that pull back NT to buy now
Oh my F god!
¦ KEEP an eye on stock market minnow OKYO Pharma in the coming days.
The Mail on Sunday understands a well-respected healthcare executive is close to joining the company, which should help the group in its development of a blockbuster dry eye treatment.
The talk is that OKYO Pharma’s treatment could compete with the likes of Restasis, which is owned by drugs giant Allergan.
Last week, the company raised £3.5 million by issuing convertible loan notes. OKYO Pharma’s shares closed at 14.75p after another strong week, but some reckon the shares can keep on climbing.
OKYO Pharma: Developing Novel Treatments for Eye Diseases - latest presentation #OKYO
https://twitter.com/zakmir/status/1290172883403026432
He has a target of 35p ( but please check)
https://twitter.com/TeaBagger18/status/1290168514506944513
https://www.youtube.com/watch?v=l8onUtOvSqQ&feature=youtu.be
should do well this week on the back of that endorsement!
This share is tipped by the Mail on Sunday today as one to keep an eye on going into next week.
iceman88, what price do you recommend we wait for here, last week you told us TILS was going to 140p , shall we wait for 6p here ?
Kunwar Shailubhai, Ph.D he is well connected CEO. He should be able to close some big deals for OKYO.
WORTH HOLDING THESE